Ensayos clínicos de Asma en Pensilvania
12 estudios sobre Asma buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
ReclutandoFase 3
Edades de 12 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07782996Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Pittsburgh
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 10 nov 2026 · NCT06307665A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research Associates of Central PA, LLC, DuBois
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06977581A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- University of Pittsburgh Medical Center, Pittsburgh
- Allergy and Clinical Immunology Associates, Pittsburgh
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07219173A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma
- Allergy and Clinical Immunology Associates, Pittsburgh
ReclutandoFase 3
Edades de 12 a 80 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07869043Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Philadelphia
- Research Site, Smithfield
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 oct 2026 · NCT06932263Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
ReclutandoSe aceptan voluntarios sanos
Edades de 8 a 70 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06512064A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, DuBois
- GSK Investigational Site, Wyomissing
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT07456033Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT04743791A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Pittsburgh
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07532265A Study of CDX-622 in Participants With Mild to Moderate Asthma
- University of Pittsburgh Asthma and Environmental Lung Health Institute at UPMC, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jul 2026 · NCT07330778Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jul 2026 · NCT06979323De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.